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Abstract
Objectives: To explore mental and somatic health, quality
of life, alcohol-related problems, sleep problems, and
diabetes related distress in university students with type 1
diabetes (T1D), compared to students without T1D. Further,
we evaluated associations with gender, treatment modal-
ities, and achieved metabolic control.
Methods: All fulltime Norwegian students aged 18–35
years pursuing higher education in 2018 (n=162.512) were
invited into a comprehensive national survey on health
and well-being. Students that stated having diabetes was
asked further questions about their diabetes care.
Results: Of 49,684 participating students, 324 participants
stated having T1D. Students with T1D did not show more
mental or somatic health symptoms, or report a higher
level of loneliness. However, T1D was significantly asso-
ciated with lower quality of life (QoL). Students with good
metabolic control reached the same QoL as students
without T1D. Mental disorders and suicidality were asso-
ciated with lacking metabolic control. The proportion of
unhealthy drinking habits was generally low, and even
lower in students with T1D. Sleeping patterns were gener-
ally good, but students using continuous glucose
measurement were awakening more often during sleep.
Females with T1D showed higher levels of diabetes related
problems and distress, but good metabolic control was
associated with lower diabetes distress level.
Conclusions: Students with T1D scored equally on most
mental and somatic health scales. Their quality of life was
significantly worse compared to their healthy peers.
Knowledge on the impact of metabolic control, gender and
the use of CSII and CGM can be valuable for the caretakers
of young adults with T1D.
Keywords: alcohol; CGM; CSII; diabetes mellitus; mental
health; quality of life; sleep; students; type 1; young adult.
Introduction
Life with type 1 diabetes (T1D) is demanding inmany ways.
The attempt to keep blood glucose in an acceptable range,
to avoid acute and chronic complications, can be both time
consuming and cognitively challenging. Norwayhas one of
the highest incidence rates of T1D in the world [1]. Conse-
quently, the proportion of university students with T1D in
Norway is relatively high. The incidence of T1D has been
increasing over the last decades, and is expected to in-
crease further in the future [2].
Norwegian university students experience quite
optimal conditions for their studies, and support in the
management of their disease: Young adults in Norway
have access to education free of tuition fees at public uni-
versities. The Norwegian State Educational Loan Fund
provides loans and grants to all university students to give
the same possibilities for education, regardless of eco-
nomic and social background, age, gender, and physical
disabilities. The Norwegian health care system covers all
eventual costs for medical consultations and treatment,
including continuous glucose monitoring (CGM) and in-
sulin pumps, exceeding approximately $200 per year.
Nevertheless, there is reason to believe that T1D can
lead to secondary mental and somatic health problems. A
higher degree of anxiety and poorer quality of life (QoL)
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have been reported, and an increase in depressive symp-
toms from adolescence to early adulthood in students
[3–5].
The primary aim of this study was to compare the
occurrence of symptoms related to mental and somatic
health, mental disorders, QoL, loneliness, positive affect,
alcohol-related problems, and sleep problems between
university students with T1D vs. those without T1D. Sec-
ondary aims were to identify possible associations to
gender, the use of diabetes treatment modalities, and
achieved metabolic control.
Materials and methods
In 2018, a cross sectional national survey of all students pursuing
higher education in Norway was conducted (the SHoT2018 study
(Students’ Health and Wellbeing Study) [6]. The overall aim of the
SHoT study was to examine the prevalence and trends across a range
of health problems and life challenges among college and university
students. Since T1D has a high prevalence in Norway, it was also part
of the survey to illuminate the specific challenges and concerns of
students with this disease.
Procedure
The SHoT2018 survey was conducted between February 6 and April 5,
2018. All fulltime Norwegian students aged 18–35 years pursuing
higher education were invited to participate. In all, 162,512 students
fulfilled these inclusion criteria, of which 49,684 students completed
the relevant questionnaires used in the present study, yielding a
response rate of 31%. Detailed information on the procedure has
already been published [6, 7].
Instruments
Somatic health symptoms
Somatic health was assessed by the Somatic Symptom
Scale-8 (SSS-8): An 8-item reliable and valid self-report
measure of somatic symptom burden originally derived
from the well-validated PHQ-15 [8]. The Cronbach’s alpha
for the SSS-8 in the current study was 0.82.
Mental health symptoms
Mental health symptoms were assessed using The Hopkins
Symptoms Checklist (HSCL-25) [9], a screening tool
designed to detect symptoms of anxiety and depression. It
is composed of a 10-item subscale for anxiety and a 15-item
subscale for depression, with each item scored on a Likert
scale from 1 (“not at all”) to 4 (“extremely”). Previous
studies have shown that an unidimensional model had the
best psychometric properties in the student population and
not the original subscales of anxiety and depression [10].
Consequently, we chose to compute a single total scale
representing common mental health symptoms in the
present study. The Cronbach’s alpha for the HSCL-25 in the
current study was 0.94.
Mental disorders
Self-reported mental disorders were assessed using the
same predefined list that was used to identify diabetes.
The list was based on a similar operationalization used
in previous large population-based studies (the HUNT
study [11]), and included several subcategories for most
conditions/disorders. In the present study, only anxiety
and depressive disorder were used. The rationale for
including both the HSCL-25 and the items of self re-
ported anxiety and depression, was to provide both an
assessment of overall symptom load (from the HSCL-25),
and an indication of the presence of depression and
anxiety.
Suicidal ideation, suicidal behavior, and self
harm
History of suicidal ideation, suicide attempts, and non-
suicidal self harm (NSSH) were assessed with 3 items
drawn from the Adult Psychiatric Morbidity Survey (APMS)
[12]; “Have you ever seriously thought of taking your life, but
not actually attempted to do so?”, “Have you ever made an
attempt to take your life, by taking an overdose of tablets or
in some other way?”, and “Have you ever deliberately
harmed yourself in any way but not with the intention of
killing yourself? (i.e., self-harm),” respectively. The ques-
tions about self harm thoughtswere adapted from theChild
and Adolescent Self harm in Europe (CASE) study [13].
“Have you ever seriously thought about trying to deliberately
harm yourself but not with the intention of killing yourself but
not actually done so?” (Yes/no). The Cronbach’s alpha for
the 4 items was 0.72.
Loneliness
Loneliness was assessed using an abbreviated version
of the widely used UCLA Loneliness Scale, “The Three-
Item Loneliness Scale (T-ILS)” [14]. The T-ILS include
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the following 3 items, each rated along a 5-point Likert
scale (1 = “never”, 5 = “very often”). For each question
below, please indicate how often you have felt that way
during the last year: 1) How often do you feel that you lack
companionship? 2) How often do you feel left out? and 3)
How often do you feel isolated from others? Higher scores
indicate higher level of experienced loneliness. The
Cronbach’s alpha for the T-ILS in the present study was
0.88.
Positive affect
The Positive andNegative Affect Schedule (PANAS) [15] is a
20-item questionnaire with two subscales, measuring
positive and negative affect (PA/NA). The NA subscale was
not included in this study. Participants were instructed to
rate to what extent they experience each emotion right
now, rated on a 5-point scale from (1 = “very slightly or not
at all” to 5 = “extremely”). A sum score was calculated with
higher scores representing greater positive affect. The
Cronbach’s alpha for the positive affect subscale in the
present study was 0.91.
Quality of life
Quality of life was assessed by the Satisfaction with Life
Scale (SWLS) [16]. The SWLS is a 5-item scale designed to
measure global cognitive judgments of one’s life satisfac-
tion (not a measure of either positive or negative affect).
Participants indicate howmuch they agree or disagreewith
each of the 5 items using a 7-point scale from 7 (strongly
agree) to 1 (strongly disagree). Higher scores indicate
higher QoL. Cronbach’s alpha for the SWLS in the present
study was 0.89.
Alcohol-related problems
Potential alcohol-related problems were measured by the
Alcohol UseDisorders Identification Test (AUDIT), which is
a widely used instrument developed by the World Health
Organization for identifying risky or harmful alcohol use
[17, 18]. The 10-item AUDIT includes items for measuring
the frequency, typical amount and episodic heavy drinking
frequency (items 1–3), alcohol dependence (items 4–6) and
problems related to alcohol consumption (items 7–10) [19].
A score of eight or more is associated with harmful or
hazardous drinking. Cronbach’s alpha for the SWLS in the
present study was 0.76.
Sleep variables
The participants’ self-reported usual bedtime and rise time
were indicated in hours and minutes, and data were re-
ported separately for weekdays andweekends. Time in bed
(TIB)was calculated as the difference betweenbedtime and
rise time. Sleep onset latency (SOL) and wake after sleep
onset (WASO) were indicated in hours and minutes. Sleep
duration was defined as TIB minus SOL and WASO.
All participants also indicated the number of nights
per week they experienced difficulties initiating sleep
(DIS), difficulties maintaining sleep (DMS), and early
morning awakenings (EMA), and daytime sleepiness and
tiredness. Those suffering from sleep problems were asked
how long the problems had been present. The following
three criteria were used as an operationalization for
insomnia disorder [20], in line with the DSM-5 criteria: 1)
the presence of either DIS, DMS, or EMA for at least three
nights per week, 2) the presence of daytime sleepiness and
tiredness for at least three days per week, and 3) a duration
of the sleep problems for at least three months.
Diabetes-related characteristics
Physical conditions were assessed by a predefined list
adapted to fit this age cohort, which also included “dia-
betes”. If the student indicated “yes” for diabetes, several
additional questions would be asked, as described previ-
ously [7]. In short, students stated their type of diabetes and
their last HbA1c value. They also reported whether they
used an insulin pen or pump, and whether they used CGM
or not. Students were also asked about the frequency of
their blood glucose measurements.
In addition, all students reporting to have diabetes
completed two brief questionnaires assessing diabetes-
related distress: the problem areas in diabetes scale
(PAID-1) [21] and the diabetes distress scale (DDS2) [22].
At the time of data collection, an HbA1c under
58 mmol/mol (7.5%) was the recommended treatment goal
from the International Society of Pediatric and Adolescent
Diabetes (ISPAD). We therefore categorized our study
sample into students reporting an HbA1c value under
58 mmol/mol (7.5%) and students with an HbA1c of
58 mmol/mol (7.5%) or higher.
Statistical analysis
We used IBM SPSS Statistics 26 for Windows (SPSS Inc.,
Chicago, IL) for all analyses. Chi-squared tests and
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independent samples t-tests were used to examine differ-
ences on the outcome measures among students with and
without T1D.We also compared T1D students achieving the
HbA1c treatment goal (58 mmol/mol, 7.5%) to students not
achieving the treatment goal. Sum scoreswere converted to
standardized t-scores to ease the comparison across the
instruments, and between-group effect sizes (pooled SD)
were calculated using the Cohen’s d formula [23]. Esti-
matedmarginalmeans (adjusting for age of diabetes onset)
were computed for diabetes-related problems and distress
in males and females with T1D by HbA1c treatment goal.
We also examined diabetes-related problems and distress
by demographic and diabetes-related variables. There was
generally little missing data, and hence missing values
were handled using listwise deletion.
Ethics
The SHoT2018 study was approved by the Regional Com-
mittee for Medical and Health Research Ethics in Norway
(no. 2017/1176). An electronic informed consent was ob-
tained after the participants had received a detailed
introduction to the study.
Results
Mental and somatic health
As displayed in Figure 1, university students with T1D did
on a general level not differ from students without T1D on
most of the health domains, with similar levels of mental
health symptoms, somatic symptoms, loneliness, and
positive affect. However, students with T1D reported lower
quality of life (Cohen’s d = 0.18, p<0.01), and fewer alcohol
problems (Cohen’s d = 0.17, p<0.01) than students without
T1D. Significantly fewer students with T1D had an alcohol
use classified as problematic or harmful (AUDIT >8)
compared to students without T1D (47.2 vs. 56.5%,
p<0.001).
Compared to students not achieving the HbA1c treat-
ment goal (58 mmol/mol, 7.5%), students achieving this
goal scored better across all health questionnaires.
Achieving the treatment goal was associated with fewer
mental health symptoms, less somatic symptoms, less
loneliness, and higher levels of quality of life and positive
affect (Figure 1).
Importantly, compared with students without T1D,
students with T1D who did achieve the HbA1c treatment
goal had significantly fewer mental health symptoms
(p=0.008) and somatic symptoms (p=0.009), and also
scored significantly better on positive affect measure
(p=0.012). The groups did not differ significantly on
reported quality of life and loneliness.
Mental disorders and suicidality
There was no significant difference between students with
T1D compared to those without T1D regarding mental dis-
orders and suicidality (Table 1). However, students not
achieving the HbA1c treatment goal had higher rates of
both anxiety and depressive disorders, and NSSH, NSSH
thoughts and suicidal thoughts, compared to students
achieving the HbA1c treatment goal (Table 1).
Figure 1: Somatic and mental health among
students with and without T1D, and by
HbA1c treatment goal (Estimates
represented in t-scores (in bars) and
Cohen’s d effect size (in white text box).
Error bars represent 95% confidence
intervals. ***p<0.001; **p<0.01; *p<0.05.
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Sleep problems
As detailed in Table 2, there were no significant differ-
ences between students with andwithout T1D acrossmost
sleep parameters, with the exception of 10–13 min later
reported bedtimes in the group with T1D. Achieving the
HbA1c treatment goal was associated with earlier bed-
times and rise times (week days and weekends), shorter
sleep onset latency, and higher sleep efficiency. No group
differences were observed for time in bed, sleep duration
or time wake after sleep onset. Insulin pump usage was
not associated with any of the sleep measures. However,
students using CGM had significantly longer time awak-
ening after sleep onset (WASO) than non users, both on
weekdays (25 vs. 13 min, p<0.05) and weekends (22 vs.
8 min, p<0.05). CGM users also had significantly longer
sleep onset latency (SOL) on weekends (45 vs. 34 min,
p<0.05), and shorter weekend sleep duration (8:13 vs.
8:37 h p<0.05).
Diabetes-related problems and distress
In terms ofworrying about the future and the possibility of
serious complications (PAID-1), female students with T1D
had the overall highest level of worry, especially women
not achieving the HbA1c treatment goal (Figure 2). The
same pattern was observed for the DDS-2 item assessing
feeling of failure with the diabetes routine. Males
achieving the treatment goal had the least amount of
distress, while women not meeting the treatment goal had
the most. Regarding feeling overwhelmed with the de-
mands of living with diabetes, a similar trend was
observed, with the exception of males – where reaching
the HbA1c treatment goal did not affect the level of
distress.
The overall level of diabetes-related distress and prob-
lems across demographic and other diabetes-related vari-
ables are displayed in Figure 3. High level of distress was
associated with being female, and not achieving the
HbA1c treatment goal. The level of distress was inversely
associated with blood glucose measurements, the less
frequent the measurement, the higher the distress. Usage of
CGM or insulin pumps was not associated with the level of
distress.
Discussion
In this national student survey for higher education in
Norway, we examined different aspects of the mental and
somatic health of university students with T1D. We
compared not only students with T1D with healthy con-
trols, but also evaluated associations with gender, meta-
bolic control (HbA1c), and treatment devices (insulin
pumps and CGM) in the group of students with T1D.
Existing knowledge on the experienced somatic and
mental health problems among students with T1D is
limited, and based on qualitative studies or studies with
few participants [3, 5]. With our study, we supply detailed
data from a large cohort of students with T1D.
The study has several strengths: We provide a large
reference group of approximately 50.000 students. The
survey includes a wide range of detailed quantitative data
regarding somatic and mental health, including gender
aspects, level of glycemic control, and use of technical
devices. The percentage of students with T1D in our cohort
(0.65%) is in line with the prevalence of the disease in the
Norwegian population [24]. Male and female participation
(0.8 vs. 0.6%) reflects the known difference in the inci-
dence of T1D regarding gender [1]. Also, the large propor-
tion of female students in our cohort is in line with the
Table : Mental disorders, insomnia, and suicidality among students with and without TD, and by HbAc treatment goal ( mmol/mol,
.%).





% (n) % (n) % (n) % (n)
Anxiety disorder .% (,) .% () NS .% () .% () .
Depressive disorder .% (,) .% () NS .% () .% () .
Insomnia disorder .% (,) .% () NS .% () .% () NS
NSSH .% (,) .% () NS .% () .% () .
NSSH thoughts .% (,) .% () NS .% () .% () <.
Suicide attempt .% () .% () NS .% () .% () NS
Suicide thought .% (,) .% () NS .% () .% () .
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Norwegian student community. Our data should therefore
be representative for the Norwegian student group. As a
limitation of the study, we have a modest response rate of
31%. Further, our results might give an underestimation of
symptoms, since non participants of health surveys tend to
have worse health than participants [25].
Mental and somatic health
Chronic diseases such as T1D are likely to affect quality
of life. Students with T1D reported a lower quality of life
compared to their healthy peers. A previous study in
adolescents aged 13–19 years with type 1 diabetes
showed no differences in QoL compared to healthy peers
[26]. During transition to adulthood, the perceived QoL
might change because of the diverse challenges of being
a young adult and additionally a university student.
However, students with well-regulated T1D reported a
quality of life equal to those without diabetes. It is
reassuring that students with T1D did not have more
mental health problems or somatic symptoms, or report
a higher level of loneliness. Students with good meta-
bolic control had even better scores than their healthy
Table : Sleep characteristics among students with and without TD, and by HbAc treatment goal ( mmol/mol, .%).






















Bedtime : : : : <. : : : : <.
Risetime : : : : NS : : : : .
Time in bed : : : : NS : : : : NS
Sleep onset latency : : : : NS : : : : .
Wake after sleep
onset
: : : : NS : : : : .
Sleep duration : : : : NS : : : : NS
Sleep efficiency, % .% . .% . NS . . . . .
Weekends
Bedtime : : : : . : : : : .
Risetime : : : : . : : : : .
Time in bed : : : : NS : : : : NS
Sleep onset latency : : : : NS : : : : .
Wake after sleep
onset
: : : : NS : : : : NS
Sleep duration : : : : NS : : : : NS
Sleep efficiency, % .% . .% . NS . . . . .
Tests are adjusted for all pairwise comparisons using the Benjamini-Hochberg correction.
Figure 2: Problems (PAID-1) and distress
(DDS-2) in males and females with type 1
diabetes (T1D) by HbA1c. Error bars repre-
sent 95% confidence intervals. Note: The
superscript letters (a, b, and c) behind the
values are used to indicate pairwise com-
parisons and whether these comparisons
are statistically different. Values in the
same row not sharing the same subscript
letter are significantly different at p<0.05
(adjusted for multiple comparisons using
the Benjamini–Hochberg correction).
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peers in some areas, such as mental health problems,
somatic symptoms, and loneliness.
In contrary to existing data from other countries, prob-
lematic alcoholusewas less common inNorwegian students
with T1D [27, 28]. A review by Pastor et al. (2017) has shown
partly dangerous and excessive drinking habits in subjects
with T1D, mostly in a higher degree than in the general
population, but at least at the same level [27]. Alcohol
misuse is a major factor for premature death, known to ac-
count for approximately 10% of deaths among adults in the
United States [29]. Lunstead et al. (2019) reported that even
though amajority of adolescents with T1Dwere asked about
their alcohol use by a healthcare provider, only 2% reported
receiving the message “I should not drink” [30]. The low
incidenceof alcohol relatedproblems inour total cohort, but
even lower incidence in the group of students with diabetes,
might imply that the Norwegian attempts to address this
problematic area during follow-up in adolescent diabetes
care are effective. This isof special interest, given thepaucity
of evidence on interventions tominimize the risks of alcohol
in young adults with diabetes [31].
Mental disorders and suicidality
In line with published meta analyses [32, 33], our data did
not show an increased occurrence of anxiety or depression
in students with T1D on a general level. However, our data
supply to existing knowledge by showing that anxiety,
depressive disorders, nonsuicidal self harming thoughts,
and suicidal thoughts were significantly more common in
students who could not reach the HbA1c target.
Sleep problems
Sleep is important tomaster challenges during the day. The
demanding self management of T1D, but also acute
complications such as hypoglycemia or psychological as-
pects can lead to disturbed sleep patterns (restriction,
deprivation, and fragmentation) [34]. Sleep quality has
been reported to be poorer in both children and adults with
T1D [35, 36]. In our study, we could observe that students
both with and without T1D obtained the recommended
sleeping duration of 7–9 h [37]. Our data are in line with a
review from Griggs et al. (2019), describing sleep duration
in young adults with T1D to be comparable to healthy
controls. A connection between poor sleep quality in ad-
olescents with T1D and increased HbA1c has also been
shown recently [38]. Our data are in line with the results
from von Schnurbein et al. (2018) showing a connection
between reaching an HbA1c below 7.5% (58 mmol/mol)
and shorter sleep onset latency, and higher sleep
efficiency.
Knowledge on the use of CGM and sleeping patterns is
still limited. Jaser et al. (2017) reported no correlation be-
tween the use of CGM or insulin pumps and the sleep of
children with T1D [39]. A newly published brief report by
Sinisterra et al. (2020) focused on the use of CGM and sleep
in young children with T1D [40]. Their data on CGM were
more nuanced, showing that the child’s sleep was less
disturbed under the use of CGM,whereas the parents’ sleep
wasmore disturbed. Our results on university students’use
of CGM are in line with the later: CGM users needed longer
to start sleeping, were more awake during sleep, and in all
slept shorter. If the observed differences in sleep were
caused by important information by the CGM system, and
resulted in a reaction by the student that improved the
quality of diabetes selfmanagement, the benefit of CGM
would outweigh the resulting differences in sleep. We
believe that a large amount of sleep disturbances by CGM
can be valuable, and sleeping through e.g., a hypoglyce-
mic episode would be the worse alternative. As an impli-
cation for the clinician, the CGM related differences in
sleeping patterns should be addressed with the patient,
Figure 3: Average score of problems (PAID-1)
and distress (DDS-2) across demographic
and diabetes-related variables. Bars repre-
sent estimated marginal means (EMM)
adjusted for age at diabetes onset and sex.
Error bars represent 95% confidence in-
tervals.
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and possible unnecessary nightly alarms and disturbance
by the device should be critically evaluated. Exact data on
the reason for the described differences in sleep in the CGM
user group are lacking, and could be the focus of future
studies.
Diabetes-related problems and distress
We observed noticeable results on the level of diabetes-
related problems and distress. Both worrying about the
future and the possibility of complications and the feeling
of failing with diabetes routines were associated with
reaching or not-reaching the HbA1c treatment goal. The
use of CSII or CGM was not associated with less diabetes
related problems or distress. However, there was a clear
gender difference. Females reported, even with a well
regulated HbA1c, more diabetes related problems and
distress compared to their male peers (Figure 2). This is
important for the clinician taking care of the young adults
with T1D. Worries and diabetes related distress have to be
addressed differently when mediating the results of self
management to their patients, knowing about these dif-
ferences. The female group might need more reassurance
when actually coping verywell inmanaging their diabetes,
whereas males might underestimate the consequences of
failing with diabetes routines.
As this national student survey for higher education in
Norway shows, university students with T1D can live their
lives equally compared to their healthy peers, regarding
most aspects of mental and somatic health. However,
students with T1D reported lower QoL compared to stu-
dents without T1D. Lower HbA1c was associated with
higher scores acrossmost health questionnaires, including
fewermental and somatic health problems, less loneliness,
higher QoL, and a more positive affect. Good metabolic
control as reflected by low HbA1c is therefore a critical
parameter for good mental and somatic health among
students with T1D.
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